IHP news 513: Access to medicines

By on March 15, 2019

Civil society letter by Oxfam & 82 other organisations- Open Letter to WHO member states   (March 6)

https://www-cdn.oxfam.org/s3fs-public/open-letter-wha-transparency-resolution-6mar2019.pdf

In this letter, Oxfam & 82 civil society organizations urge all WHO Member States to support actions to improve the transparency of medical R&D, prices, patents & clinical trials.

FT – Kelly Chibale: Overcoming sceptics at home and abroad

https://www.ft.com/content/5541440c-38ff-11e9-b856-5404d3811663

Founder of H3D is debunking the idea that Africa cannot be a leader in drug discovery”.

“… The rag in Kelly Chibale’s rags-to-riches story is the lit one he used to put into a paraffin-filled tub so that he could study at night. Brought up amid violence and squalor in the Zambian copper belt settlement of Kabulanda — whose name, he says, literally denotes “sadness” — Mr Chibale has fashioned a successful career from a tough start. The 54-year-old is the founder and director of H3D, Africa’s only fully integrated drug discovery centre, which in 2017 became the first to put an “African drug” — an anti-malarial — into Phase II clinical trials. A member of the Royal Society of Chemistry, in 2018 he was named by Fortune as one of the world’s top 50 leaders….”

HPW – Delay Vote On Cannabis Reclassification – Chair Of UN Commission On Narcotic Drugs Recommends

https://www.healthpolicy-watch.org/delay-vote-on-cannabis-reclassification-chair-of-un-commission-on-narcotic-drugs-recommends/

The UN Commission on Narcotic Drugs appears set to delay any consideration this year of a recent World Health Organization recommendation to reschedule the status of cannabis and cannabis-related substances from “particularly dangerous” to a less dangerous category – with no timeline indicated for when the Commission might actually take up the contentious issue….”

Leave a reply
Print Friendly, PDF & Email